If you take levothyroxine, plan for potentially more frequent thyroid function monitoring during the first few months and after significant weight loss
Current Data in Oncology Population GLP-1 RAs and Risk for Thyroid Cancer As previously stated, the packaging of GLP-1 RAs includes a boxed warning for thyroid cancers, but what can the studies in human participants tell us about this risk ( Table 3 )
Read our deeper guide on medical weight loss with GLP-1 medications for clinical details on how these medications work and how they compare
Dietitians can assess micronutrient intake and recommend targeted supplementation when indicated
This is important for two reasons
The top doctors at Blue Fin Vision explain that this occurs because sudden changes in glucose levels can destabilise the fragile blood vessels in the retina, potentially causing: Retinal haemorrhaging Macular oedema (fluid accumulation in the central vision area) Temporary vision fluctuations Blurred vision due to refractive changes Symptoms and Warning Signs Patients taking GLP-1 medications should remain vigilant for specific symptoms that warrant immediate attention from top specialists: Immediate Concern Symptoms: Sudden, painless vision loss in one or both eyes Rapidly worsening eyesight New onset of persistent blurred vision Floaters or flashing lights Central vision disturbances Early Warning Signs: Gradual vision changes over weeks Difficulty with night vision Fluctuating vision throughout the day New visual field defects The best eye care professionals at our London clinics emphasise that any sudden vision changes during GLP-1 treatment require urgent evaluation
